Press releases

Filter
142 found

Artemisinin’s key impurities identified and made available as reference standards

20 Jun 2011

MMV supports new technique to measure quality of artemisinin

06 Jun 2011

MMV participates in Asia Pacific efforts to eliminate malaria

25 May 2011

Sanofi-aventis and MMV join forces to develop innovative malaria drugs

05 May 2011

"SMS for Life" rolled-out nationwide in the United Republic of Tanzania

18 Apr 2011

Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria

18 Mar 2011

Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin

15 Feb 2011

Single-dose cure for malaria edges closer to the clinic

08 Feb 2011

International status granted to three not-for-profit organizations in Switzerland

09 Dec 2010

MMV, Novartis and partners discover novel antimalarial drug candidate

03 Sep 2010

MMV becomes first PDP to make its IP freely available for neglected diseases research

16 Aug 2010

MMV to screen Ferrer compound library

15 Jul 2010

AstraZeneca and MMV join efforts in the fight against malaria

28 Jun 2010

Data from MMV-supported research now in the public domain

20 May 2010

MMV and Anacor join hands in hunt for new antimalarial compounds

26 Apr 2010

MMV supports trials of a new preventive treatment option for pregnant women

23 Apr 2010

Pyramax® submitted to EMA for regulatory approval

08 Apr 2010

MMV’s Project of the Year for 2009 goes to Spiroindolones

15 Mar 2010

MMV-GSK compound library screening to be made public

20 Jan 2010

MMV 10th Anniversary Seminars: presentations and video clips

04 Dec 2009

MMV’s President and CEO to step down in 2010

23 Nov 2009

MMV and sanofi-aventis launch ambitious antimalarial monitoring programme

19 Nov 2009

MMV receives $115 million from Gates Foundation

19 Oct 2009

MMV and Treague take development of (+) Mefloquine into Phase I

10 Jul 2009

Dihydroartemisinin-piperaquine submitted to EMEA for regulatory approval

06 Jul 2009

Pfizer and MMV advancing international research efforts in the fight against malaria

22 Apr 2009

MMV and Merck & Co. to develop promising antimalarial compound

18 Mar 2009

MMV and Novartis launch Coartem® Dispersible

20 Feb 2009

MMV and Novartis launch Coartem® Dispersible in Africa

15 Feb 2009

Unique collaboration launches a new malaria medicine to save millions of children

27 Jan 2009

First-ever comprehensive report on the antimalarials market in Uganda shows how understanding markets can help improve access to medicines

05 Nov 2008

MMV signs MOU with sanofi-aventis

22 Oct 2008

Unforgettable launch of MMV-MOH Uganda pilot

22 Sep 2008

Genzyme Corporation and MMV Announce New Collaboration with Advinus Therapeutics to Accelerate Discovery of Novel Therapies for Malaria

26 Aug 2008

Spain becomes a major government funder of MMV

31 May 2008

Dacart development halted based on Phase III results

29 Feb 2008

MoH - MMV: Bold intervention being designed in Uganda to deliver subsidized effective antimalarials

01 Oct 2007

US NIH grants MMV over USD 5 mn for malaria research

06 Sep 2007

Start of Phase II trial of intravenous artesunate for children with severe malaria

29 Aug 2007

Uganda and MMV explore innovative ways to give patients access to life-saving antimalarials

09 May 2007

Pivotal clinical trials launched for new artemisinin-based malaria drug combination

25 Jan 2007

Malaria Map: New Tool for Malaria Control

06 Dec 2006

Medicines for Malaria Venture, Higher Colleges of Technology and Global Medical Forum Foundation Collaborate on Innovative Abu Dhabi Bio City Research Initiative to Tackle Malaria

18 Oct 2006

MMV announces a commitment of US$50 million to advance malaria research at President Clinton’s Global Initiative

21 Sep 2006

Pivotal Studies Begin for CDA in sub-Saharan Africa

25 Jul 2006

Novartis spearheads innovative malaria research project in newly created public-private partnership

23 May 2006

Irish Aid announces a grant to MMV of €9 million over the next three years

11 May 2006

MMV Stakeholders’ Meeting - Shin Poong Pharm. wins Project of the Year

06 May 2006

MMV applauds WHO’s call to halt malaria monotherapy

23 Jan 2006

University of Mississippi, MMV, and DNDi to collaborate on development of anti-parasitic drugs

14 Dec 2005

RBx11160 demonstrates significant parasite reduction in patients

13 Dec 2005

New ACT confirms potential use against malaria

13 Nov 2005

Gates Foundation commits $258.3 mn for malaria R&D with $100 mn for MMV

31 Oct 2005

DfID and the Wellcome Trust announce new grant for MMV

29 Oct 2005

Dihydroartemisinin and Piperaquine could become a major weapon against malaria

03 Oct 2005

Pyronaridine-Artesunate (PANDA)

15 Aug 2005

GlaxoSmithKline and University of California, San Francisco win Medicines for Malaria Venture’s Project of the Year 2004 Award

29 May 2005

MMV and GlaxoSmithKline collaborate to fight malaria

11 Nov 2004

USAID announces $16 million for new malaria initiatives, $8 million for MMV

27 Oct 2004

BHP Billiton joins Medicines for Malaria Venture in the fight against malaria

02 Jun 2004

Pages